Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6096555 | Gastroenterology | 2010 | 8 Pages |
Abstract
Induction of HBeAg seroconversion by nucleos(t)ide analogues is temporary in most patients with chronic HBV infection. Long-term continuation of nucleos(t)ide analogue treatment, irrespective of the occurrence of HBeAg seroconversion, appears to be necessary.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Jurriën G.P. Reijnders, Moniek J. Perquin, Ningping Zhang, Bettina E. Hansen, Harry L.A. Janssen,